Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

North American Prodromal Synucleinopathy Consortium Stage 2

NCT05826457 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05826457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05826457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
North American Prodromal Synucleinopathy Consortium Stage 2
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 12, 2022
Completion date
May 1, 2028
Enrollment
500 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with lewy bodies, lewy body dementia, multiple system atrophy, parkinson disease, rem sleep behavior disorder, rem sleep parasomnias